Hims & Hers Health ( (HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hims & Hers Health’s stock is experiencing a downturn as Bank of America anticipates the company’s Q3 revenue to meet expectations, but predicts a weaker Q4 due to deferred revenue issues. The bank has revised its Q4 revenue forecast downward, pointing to weaker sales in September, leading analysts to maintain a cautious outlook and impacting the company’s revenue guidance.
More about Hims & Hers Health
YTD Price Performance: 131.15%
Average Trading Volume: 30,015,333
Technical Sentiment Signal: Buy
Current Market Cap: $13.15B
For further insights into HIMS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.